Loading clinical trials...
Loading clinical trials...
Randomized Study of Safety and Effectiveness of Corneal Collagen Crosslinking Using Two Different Riboflavin Administration Protocols
Conditions
Interventions
Riboflavin
Riboflavin
Locations
1
United States
Cornea and Laser Eye Institute, Hersh Vision Group
Teaneck, New Jersey, United States
Start Date
June 2, 2021
Primary Completion Date
June 1, 2025
Completion Date
December 1, 2025
Last Updated
January 4, 2023
NCT07372911
NCT06451718
NCT02118922
NCT04094090
NCT04570020
NCT03504800
Lead Sponsor
Cornea and Laser Eye Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions